• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用麻疹和风疹快速诊断检测来改善病例发现及疫苗接种目标定位。

Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.

作者信息

Rachlin Audrey, Hampton Lee M, Rota Paul A, Mulders Mick N, Papania Mark, Goodson James L, Krause L Kendall, Hanson Matt, Osborn Jennifer, Kelly-Cirino Cassandra, Evans Beth, Sinha Antara, Warrener Lenesha, Featherstone David, Brown David

机构信息

Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

出版信息

Vaccines (Basel). 2024 Jul 23;12(8):823. doi: 10.3390/vaccines12080823.

DOI:10.3390/vaccines12080823
PMID:39203949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11360261/
Abstract

Efforts to control and eliminate measles and rubella are aided by high-quality surveillance data-supported by laboratory confirmation-to guide decision-making on routine immunization strategies and locations for conducting preventive supplementary immunization activities (SIAs) and outbreak response. Important developments in rapid diagnostic tests (RDTs) for measles and rubella present new opportunities for the global measles and rubella surveillance program to greatly improve the ability to rapidly detect and respond to outbreaks. Here, we review the status of RDTs for measles and rubella Immunoglobulin M (IgM) testing, as well as ongoing questions and challenges regarding the operational use and deployment of RDTs as part of global measles and rubella surveillance. Efforts to develop IgM RDTs that can be produced at scale are underway. Once validated RDTs are available, clear information on the benefits, challenges, and costs of their implementation will be critical for shaping deployment guidance and informing country plans for sustainably deploying such tests. The wide availability of RDTs could provide new programmatic options for measles and rubella elimination efforts, potentially enabling improvements and flexibility for testing, surveillance, and vaccination.

摘要

高质量的监测数据(辅以实验室确认)有助于麻疹和风疹的控制与消除工作,为常规免疫策略以及开展预防性补充免疫活动(SIAs)和疫情应对的地点提供决策依据。麻疹和风疹快速诊断检测(RDTs)的重要进展为全球麻疹和风疹监测计划带来了新机遇,极大地提升了快速检测和应对疫情的能力。在此,我们回顾了麻疹和风疹免疫球蛋白M(IgM)检测的RDTs现状,以及将RDTs作为全球麻疹和风疹监测一部分进行操作使用和部署时存在的问题与挑战。目前正在努力开发能够大规模生产的IgM RDTs。一旦获得经过验证的RDTs,有关其实施的益处、挑战和成本的清晰信息对于制定部署指南以及为各国可持续部署此类检测的计划提供参考至关重要。RDTs的广泛应用可为麻疹和风疹消除工作提供新的规划选项,有可能在检测、监测和疫苗接种方面实现改进并提高灵活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526c/11360261/2ec36f679bff/vaccines-12-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526c/11360261/e7510f9b3d9a/vaccines-12-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526c/11360261/2ec36f679bff/vaccines-12-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526c/11360261/e7510f9b3d9a/vaccines-12-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526c/11360261/2ec36f679bff/vaccines-12-00823-g002.jpg

相似文献

1
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.使用麻疹和风疹快速诊断检测来改善病例发现及疫苗接种目标定位。
Vaccines (Basel). 2024 Jul 23;12(8):823. doi: 10.3390/vaccines12080823.
2
Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.通过横断面网络调查确定加速实现麻疹和风疹消除的研究重点。
Vaccine. 2019 Sep 10;37(38):5745-5753. doi: 10.1016/j.vaccine.2019.02.058. Epub 2019 Mar 18.
3
Strengthening routine immunization through measles-rubella elimination.通过消除麻疹和风疹来加强常规免疫。
Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21.
4
Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.消除风疹的进展 - 世界卫生组织欧洲区域,2005-2019 年。
MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):833-839. doi: 10.15585/mmwr.mm7023a1.
5
Measles, mumps, rubella prevention: how can we do better?麻疹、腮腺炎、风疹预防:我们如何做得更好?
Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7.
6
The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.全球麻疹和风疹实验室网络支持高质量监测。
Vaccines (Basel). 2024 Aug 22;12(8):946. doi: 10.3390/vaccines12080946.
7
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.全球麻疹和风疹实验室网络对消除目标的支持,2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3.
8
Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.迈向消除麻疹的进展 - 东南亚区域,2003-2020 年。
MMWR Morb Mortal Wkly Rep. 2022 Aug 19;71(33):1042-1046. doi: 10.15585/mmwr.mm7133a2.
9
Progress Toward Measles and Rubella Elimination - India, 2005-2021.迈向消除麻疹和风疹的进展 - 印度,2005-2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1569-1575. doi: 10.15585/mmwr.mm7150a1.
10
Tracking Measles and Rubella Elimination Progress-World Health Organization African Region, 2022-2023.追踪麻疹和风疹消除进展——世界卫生组织非洲区域,2022 - 2023年
Vaccines (Basel). 2024 Aug 22;12(8):949. doi: 10.3390/vaccines12080949.

引用本文的文献

1
Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023.2019年至2023年期间,全球及世界卫生组织各区域的麻疹疫苗接种覆盖率和抗麻疹群体免疫水平有所恶化。
Vaccines (Basel). 2025 Feb 5;13(2):157. doi: 10.3390/vaccines13020157.

本文引用的文献

1
Immunization agenda 2030: A global strategy to leave no one behind.《2030年免疫议程:不让任何人掉队的全球战略》
Vaccine. 2024 Apr 8;42 Suppl 1:S5-S14. doi: 10.1016/j.vaccine.2022.11.042.
2
Progress and Challenges in Measles and Rubella Elimination in the WHO European Region.世界卫生组织欧洲区域消除麻疹和风疹的进展与挑战
Vaccines (Basel). 2024 Jun 20;12(6):696. doi: 10.3390/vaccines12060696.
3
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001-2023.2001 - 2023年全球麻疹和风疹防控伙伴关系的演变与贡献
Vaccines (Basel). 2024 Jun 20;12(6):693. doi: 10.3390/vaccines12060693.
4
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.快速诊断检测:高优先级病原体爆发防范和应对的关键需求。
BMJ Glob Health. 2024 Apr 30;9(4):e014386. doi: 10.1136/bmjgh-2023-014386.
5
A measles IgM rapid diagnostic test to address challenges with national measles surveillance and response in Malaysia.一种麻疹 IgM 快速诊断检测方法,旨在解决马来西亚国家麻疹监测和应对工作中的挑战。
PLoS One. 2024 Mar 14;19(3):e0298730. doi: 10.1371/journal.pone.0298730. eCollection 2024.
6
Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.消除风疹和先天性风疹综合征的进展 - 全球,2012-2022 年。
MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):162-167. doi: 10.15585/mmwr.mm7308a2.
7
Evaluation of a rapid diagnostic test for measles IgM detection; accuracy and the reliability of visual reading using sera from the measles surveillance programme in Brazil, 2015.评价麻疹 IgM 检测的快速诊断检测试剂;使用来自巴西 2015 年麻疹监测计划的血清进行目视判读的准确性和可靠性。
Epidemiol Infect. 2023 Aug 4;151:e151. doi: 10.1017/S0950268823000845.
8
Progress Toward Regional Measles Elimination - Worldwide, 2000-2021.迈向全球消除麻疹区域目标的进展-2000-2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Nov 25;71(47):1489-1495. doi: 10.15585/mmwr.mm7147a1.
9
Vaccination strategies for measles control and elimination: time to strengthen local initiatives.麻疹控制和消除的疫苗接种策略:是时候加强地方行动了。
BMC Med. 2021 Jan 5;19(1):2. doi: 10.1186/s12916-020-01843-z.
10
Rapid diagnostic tests to address challenges for global measles surveillance.快速诊断检测应对全球麻疹监测挑战。
Curr Opin Virol. 2020 Apr;41:77-84. doi: 10.1016/j.coviro.2020.05.007. Epub 2020 Jun 29.